Sonoma Pharmaceuticals, Inc.Sonoma Pharmaceuticals, Inc.Sonoma Pharmaceuticals, Inc.

Sonoma Pharmaceuticals, Inc.

No trades
See on Supercharts

SNOA fundamentals

An in-depth look to Sonoma Pharmaceuticals, Inc. operating, investing, and financing activities

SNOA free cash flow for Q1 24 is -917 k USD. For 2023, SNOA free cash flow was -2.42 M USD and operating cash flow was -2.4 M USD.

Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
‪0.00‬
Cash from operating activities
Cash from investing activities
Cash from financing activities
Currency: USD
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
TTM
Free cash flowYoY growth